MEDVi is an AI-powered telehealth platform selling compounded GLP-1 weight loss medications, founded in September 2024 by Matthew Gallagher. The company generated **$401 million in revenue in 2025** with a net profit of $65 million — a 16.2% margin — while operating with a headcount of just two people. The platform is now on track for $1.8…
JoinSkinny Semaglutide GLP-1 Reviews and Complaints :JoinSkinny is the consumer-facing affiliate brand for SkinnyRx, a cash-pay telehealth platform that prescribes compounded semaglutide and tirzepatide for weight management. The platform is operated by Lean Rx, Inc., a Sacramento, California-based company founded in 2019. SkinnyRx is LegitScript certified, holds a BBB rating of B, and maintains a 4.8 out of 5…
Sunlight GLP-1 is a cash-pay telehealth platform that prescribes compounded semaglutide and compounded tirzepatide for weight management. It operates through a fully remote model: patients complete an online intake, a licensed clinician reviews their case, and medication ships directly to their home if approved. The company is LegitScript certified, holds a BBB accreditation, and has a…